ENDRA LIFE SCIENCES INC. Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest
ENDRA LIFE SCIENCES INC. (NDRA) reported Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest of -$11.23 million for the 12-month period ending 2021-12-31, per its 10-K filed 2022-03-30.
Discontinued › Income Statement
us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments · last filed 2022-03-30
- ENDRA LIFE SCIENCES INC. income (loss) from continuing operations before equity method investments, income taxes, noncontrolling interest for fiscal 2021 was -$11.23M.
- ENDRA LIFE SCIENCES INC. income (loss) from continuing operations before equity method investments, income taxes, noncontrolling interest for fiscal 2020 was -$11.73M.
| Period end | Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest 12 month |
|---|---|
| 2021-12-31 | -$11.23M 10-K · filed 2022-03-30 |
| 2020-12-31 | -$11.73M 10-K · filed 2022-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| IRIDEX CORP (IRIX) | United States | $0.011B | |
| Nuwellis, Inc. (NUWE) | United States | $0.003B | |
| QT IMAGING HOLDINGS, INC. (QTI) | United States | $0.037B | |
| PRECISION OPTICS CORPORATION, INC. (POCI) | United States | $0.052B | |
| Outset Medical, Inc. (OM) | United States | $0.059B | -1.09 |
| Streamex Corp. (STEX) | United States | $0.089B | -0.19 |
| Nexalin Technology, Inc. (NXL) | United States | $0.094B | |
| Neuraxis, INC (NRXS) | United States | $0.097B | |
| electroCore, Inc. (ECOR) | United States | $0.102B | |
| Vivani Medical, Inc. (VANI) | United States | $0.111B |